www.archive-org-2012.com » ORG » U » UKHRA

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".

    Archived pages: 54 . Archive date: 2012-12.

  • Title: UKHRA - The UK Harm Reduction Alliance
    Descriptive info: .. Introduction.. The United Kingdom Harm Reduction Alliance UKHRA is a campaigning coalition of drug users, health and social care workers, criminal justice workers and educationalists that aims to put public health and human rights at the centre of drug treatment and service provision for drug users.. UKHRA supports International Overdose Day.. For more information go to.. overdoseday.. com.. A number of prominent organisations, leading academics and parliamentarians have written to the Coalition Government to highlight their concerns about a new Home Office document:.. Putting Full Recovery First: A Recovery Roadmap.. This document launched on 13 March 2012 would see services receiving full payment only if people are in full recovery , which, according to the document, excludes those on substitution medications such as methadone.. Opioid substitution therapy has proven to reduce heroin use, treat opiate dependence, and reduce deaths from overdose.. It is one of the core interventions for HIV prevention relating to injecting drug use.. The.. letter and statement.. , sent on 24 April 2012, has been supported by UKHRA and other organisations working in drug treatment and harm reduction, as well as the UK Recovery Federation.. A survey carried out by UKHRA, UKRF and NUN ask those working in drug treatment and those who use drugs for their view of the Government document, a summary of the results can be.. accessed here.. Consensus statement.. defining best practice in reducing injecting related harm,.. click here.. To see the joint UKHRA/NNEF response to the Coalition's drug strategy.. We are a campaigning network spread across the UK, as well as promoting harm reduction and evidence based drug policy by writing policy proposals and responses to government consultations.. We also have several active.. email discussion lists.. If you are interested in harm reduction, we would encourage you to join one or more of our lists.. TOP.. E-mail discussion lists.. UKHRA has set up a number of email discussion groups to help inform and improve networking and the development of good practice in the field.. For an introduction to how they work - written for UKHRA Discussion, but which applies to all lists -.. For help joining the groups.. The UKHRA email lists are:.. UKHRA Announce.. An occasional list with important announcements only.. Very low traffic.. To join UKHRA announce please.. UKHRA Discussion.. An active group with lots of members discussing harm reduction policy and practice.. Questions answered, and opinions tested and an archive of over 15,000 emails available to members.. To join the UKHRA discussion list please read the.. guidelines for members.. , then.. UKHRA Needle Exchange.. An active group of drug workers, injectors, policy makers and researchers discussing policy and practice relating to needle and syringe exchange.. To join UKHRA needle-exchange please.. UKHRA Women.. UKHRA Women is a dedicated discussion forum for women who: use; are interested in; or, affected by drugs and their related issues - in particular within the arena of harm reduction.. Open to  ...   young people and drugs please.. UKHRA Users.. ukhra-users is a mailing list aimed at users and ex-users who are concerned about the state of drug treatment in the UK and wish to become involved in the process of improving that treatment.. Although some list members may be interested in wider social and political issues, things like legalization and cannabis are *not* what this group is about.. Those issues have other lists, so if you want to talk about those things, join those lists.. Who can join ukhra-users?.. This is a closed mailing list, and prospective members have to be approved.. Although primarily aimed at users and ex-users, the list will also accept membership from professionals who have a personal or professional interest in the issue of user-involvement, and they have to be nominated by a user or ex-user in order to join.. List members who are users can veto the membership of a professional if they regard that person as a threat or if they have evidence that their behavior and/or actions are consistent with those of drug users.. If this happens, the issue will be put to a vote of all members and majority decision will apply.. However we aren't seeking to be overly prescriptive about this.. If there are any professionals reading this who would like to subscribe but don't know any users with net access, feel free to email the list coordinator, to do this,.. However, be warned that we aren't letting you on board for the entertainment value.. We'll expect you to work for your access in the form of support, using your skills and experience, etc.. etc.. History of ukhra-users and UKUsers.. UKUsers was a mailing list that was established several years ago by the National Drug User Development Agency in order to bring all of the UK user activists together in one place.. Unlike ukhra-users, UKUsers was intended to be a broad church, embracing cannabis and dance drugs activists as well as people who have experienced problems with their drug use.. The National Drug Users Development Agency abandoned their involvement with UKUsers during 2002, until the formation of ukhra users the UKUsers list was run by UKHRA committee members Alan Joyce as an independent entity.. However, Alan's workload is now such that maintaining that list has become an onerous responsibility, and so we are seeking to bring those user/activists who are subscribed to that list under the ambit of the UK Harm Reduction Alliance.. How do I subscribe?.. You can either go to.. http://groups.. yahoo.. com/group/ukhra-users.. , or you can send an email to.. ukhra-users-subscribe@yahoogroups.. UKHRA was established with funding from the.. Tides Foundation.. home.. what's new.. ukhra position statements responses.. practice development.. ukhra committee.. tom waller award.. links.. Join our discussion lists.. ukhra announce.. ukhra discussion.. ukhra needle exchange.. ukhra women.. ukhra - young people.. drugs.. ukhra users.. Site design and hosting donated by Exchange Supplies: Tools for Harm Reduction..

    Original link path: /
    Open archive

  • Title: UKHRA statement: The definition of harm reduction
    Descriptive info: Harm reduction defined.. To download the original Word document (34kB),.. UKHRA.. Definition of Harm Reduction.. Many responses to drug use have been defined at some time as harm reduction , and this has led to much some confusion as to what harm reduction actually is.. In order to clarify the situation, UKHRA the UK s leading organisation campaigning for a rational, harm reduction oriented response to drug use has prepared a.. definition of harm reduction.. , and identified the core.. principles of harm reduction.. top.. Definition of harm reduction.. Harm reduction is a term that defines policies, programmes, services and actions that work to reduce the:.. health;.. social; and.. economic.. harms to:.. individuals;.. communities; and.. society.. that are associated with the use of drugs (Newcombe 1992).. 1.. The principles of harm reduction:.. The following principles of harm reduction are adapted from those set out by The Canadian Centre on Substance Abuse (CCSA 1996).. 2.. , and Lenton and Single 1998.. 3.. :.. Harm reduction:.. Is pragmatic:.. and accepts that the use of drugs is a common and enduring feature of human experience.. It acknowledges that, while carrying risks, drug use provides the user with benefits that must be taken into account if responses to drug use are to be effective.. Harm reduction recognises that containment and.. reduction of drug-related harms is a more feasible option than efforts to eliminate drug use.. entirely.. Prioritises goals:.. harm reduction responses to drug use incorporate the notion of a hierarchy of  ...   drug use have to accept this.. Focuses on risks and harms:.. on the basis that by.. providing responses that reduce risk, harms can be reduced or avoided.. The focus of risk reduction interventions are usually the drug taking behaviour of the drug user.. However, harm reduction recognises that people s ability to change behaviours is also influenced by the norms held in common by drug users, the attitudes and views of the wider community Harm reduction interventions may therefore target individuals, communities and the wider society.. Does not focus on abstinence:.. although.. harm reduction supports those who seek to moderate or reduce their drug use.. , it neither excludes nor presumes a treatment goal of abstinence.. Harm reduction approaches recognise that short-term abstinence oriented treatments have low success rates, and, for opiate users, high post-treatment overdose rates.. Seeks to maximise the range of intervention options that are available,.. and engages in a process of identifying, measuring, and assessing the relative importance of drug-related harms and.. balancing costs and benefits.. in trying to reduce them.. Newcombe, R.. (1992) The reduction of drug related harm: a conceptual framework for theory, practice and research.. In, O'Hare et al (Eds.. ) The reduction of drug related harm.. London Routledge.. CCSA (1996).. Harm Reduction: Concepts and Practice: A Policy Discussion Paper.. , Canadian Centre on Substance Abuse (CCSA) National Working Group on Policy [.. link.. ].. Lenton, S.. and Single, E.. The definition of harm reduction.. Drug Alcohol Review 17, 2: 213-220, 1998..

    Original link path: /harm_reduction_definition.html
    Open archive

  • Title: Putting Public Health First
    Descriptive info: Putting Public Health First.. BACK.. Download the.. covering letter and statement.. as a pdf.. c/o 124 128 City Road.. London.. EC1V 2NJ.. Lord Henley.. Home Office.. Direct Communications Unit.. 2 Marsham Street.. SW1P 4DF.. 24 April 2012.. Dear Lord Henley.. Please find attached a public statement that has been issued by the UK Harm Reduction Association, the UK Recovery Federation and the National Users Network, in response to the document published by the Home Office on 13 March 2012 titled Putting Full Recovery First - the Recovery Roadmap.. This statement has been supported by a number of organisations and individuals who work or are interested in the drug treatment field.. Many of the signatories and our organisations are concerned that the Home Office document ignores the evidence base for good treatment interventions and will have a negative impact on those accessing services.. The UK has long been seen as a leader in the field of drug treatment and harm reduction.. We believe it is important that we continue this excellent work and we would welcome the opportunity to meet with you to discuss our concerns.. Yours Sincerely.. Alistair Sinclair, UK Recovery Federation.. Neil Hunt, UK Harm Reduction Alliance.. Francis Cook, National Users Network.. cc.. Cabinet Office.. Department for Education.. Department of Health.. Department for Work and Pensions.. Department for Communities and Local Government.. HM Treasury.. Ministry of Justice.. Statement attached below.. In March this year, the Coalition Government released a document entitled Putting Full Recovery First , outlining a roadmap for building a new treatment system based on recovery.. It describes a new agenda focused on full independence from any chemical (which will be main measure for Payment by Results in drug treatment).. This document is intended to influence services and commissioners, but it ignores decades of evidence in drug treatment and the core principles that underpin recovery within both the substance use and mental health fields.. It will do more harm than good: increasing drug-related harm (including HIV transmission and overdose) and reducing levels of engagement with treatment services.. People living stable, fulfilling lives assisted by opioid substitution therapy (OST) will be placed in jeopardy, and scarce public funds will be wasted by undermining established, evidence-based interventions.. There has been minimal input into this Roadmap from people who use drug services or those who provide drug treatment.. Given the serious concerns that we outline below, we call for all stakeholders to be given the opportunity to contribute to a more open and inclusive policy.. Predetermined treatment goals are arbitrary, unethical and ineffective:.. Some people enter treatment to become abstinent others may not be able or willing to reach this goal.. Some people benefit from long-term OST.. 4.. 5.. others from abstinence-based programmes.. 6.. Some people s problems stem from the drug(s) that they use others from patterns or methods of drug use,.. 7.. 8.. or from homelessness, unemployment or a history of abuse.. Imposing a one-size-fits-all abstinence goal upon this diverse population is dangerous, legally problematic and may contravene medical ethics.. The Government s 2010 Drug Strategy described recovery as an individual, person-centred journey.. 9.. , i.. e.. it can mean different things to different people, and many different pathways exist (including medication assisted recovery.. 10.. ).. Services must be client-led and empowering, not predetermined in a policy document.. This is not fatalism (as the Roadmapstates) but an approach based on evidence, experience and pragmatism.. The Roadmap wilfully ignores evidence and expert guidance:.. Putting full recovery first implies all other goals including reduced HIV transmission and overdoses are secondary.. Yet interventions such as needle and syringe programmes (NSP) and OST are among the most proven, effective public health responses available.. Numerous scientific reviews have concluded in their favour in the UK.. 11.. 12.. and internationally.. 13.. 14.. 15.. Methadone, buprenorphine and naloxone are World Health Organization Essential Medicines.. 16.. The Roadmap acknowledges the evidence base underpinning effective treatment interventions , yet simultaneously ignores it.. For example, OST is cast aside in search of new evidence for new approaches (for which the Roadmap includes no provisions for rigorous evaluation).. The Roadmap represents a threat to public healthin the UK:.. The1980s Conservative Government embraced harm reduction a bold and pragmatic move that averted a major public health crisis, as we know from looking at how HIV spread in countries that were slower to respond (such as the USA, Spain and Russia).. 17.. The Roadmap, however, ignores decades of evidence and states that: It is self-evident that the best protection against blood borne viruses is full recovery.. A person who has achieved full recovery is free from drug-related risks as long as they remain abstinent.. But relapse is a reality for many people.. 18.. The risk of blood-borne viruses returns if injecting resumes, and people who relapse face heightened risks of overdose if support (and take-home naloxone.. 19.. ) is not provided.. 20.. The Roadmap states that everybody deserves a second chance , but recovery means much more than just abstinence.. Recent experiences in Greece demonstrate the danger of overlooking evidence-based responses.. HIV incidence among people who inject drugs has risen from between 9 and 16 cases annually in the preceding five years to 190 cases in 2011 alone an upsurge associated with the economic crisis and the absence of comprehensive prevention programmes.. 21.. The Coalition Government is gambling with lives by focusing on a singular, narrow vision of full recovery rather than the more open and balanced approach described in their Drug Strategy.. 22.. The Roadmap devalues evidence-based treatment and threatens  ...   Response for Prevention of HIV Among Drug Users in South Asia Through Opioid Substitution Treatment (OST): Concepts of Opioid Substitution Treatment (OST).. 2007.. Available from:.. http://www.. unodc.. org/india/ost_interventions_concepts.. html.. WHO, UNODC UNAIDS.. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention.. Geneva: World Health Organization, 2004.. McKeganey N, Bloor M, Robertson M, Neale J MacDougall J.. Abstinence and Drug Abuse Treatment: Results from the Drug Outcome Research in Scotland Study.. Drugs: Education, Prevention and Policy, 2006; 13: 537 550.. Patterns in Drug Use: Differences in Patterns of Drug Use Between Women and Men.. Lisbon: EMCDDA, 2005.. YamaguchiK Kandel DB.. Patterns of Drug Use from Adolescence to Young Adulthood: 111.. Predictors of Progression.. American Journal of Public Health, 1984; 74: 673 681.. Drug Strategy 2010: Reducing Demand, Restricting Supply, Building Recovery: Supporting People to Live a Drug Free Life.. London: HM Government; 2010.. White W, Parrino M Ginter W.. A Dialogue on the Psychopharmacology in Behavioral Healthcare: The Acceptance of Medication-Assisted Treatment in Addictions.. 2011.. williamwhitepapers.. com/pr/2011%20SAMHSA%20Acceptance%20of%20Medication-assisted%20Treatment.. pdf.. Methadone and Buprenorphine for the Management of Opioid Dependence: NICE Technology Appraisal Guidance 114.. London: National Institute for Health and Clinical Excellence; 2007.. Needle and Syringe Programmes: Providing People who Inject Drugs with Injecting Equipment: NICE Public Health Guidance 18.. London: National Institute for Health and Clinical Excellence; 2009.. Effectiveness of Drug Dependence Treatment in Preventing HIV Among Injecting Drug Users.. Geneva: World Health Organization; 2005.. Gowing L, Farrell MF, Bornemann R, Sullivan LE Ali R.. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.. Cochrane Database of Systematic Reviews, 2011; Issue 8: CD004145.. Rhodes T Hedrich D (Eds).. Harm Reduction: Evidence, Impacts and Challenges.. Lisbon: EMCDDA, 2010.. WHO Model List of Essential Medicines: 17th List (March 2011).. Geneva: World Health Organization; 2011.. Stimson GV.. AIDS and Injecting Drug Use in the United Kingdom, 1987-1993: The Policy Response and the Prevention of the Epidemic.. Social Science and Medicine, 1995; 41(5): 699 716.. Magura S Rosenblum A.. Leaving Methadone Treatment: Lessons Learned, Lessons Forgotten, Lessons Ignored.. Mount Sinai Journal of Medicine, 2001; 68: 62 74.. Best D, Man L-H, Zador D, Darke S, Bird S, Strang J Ashton M.. Overdosing on Opiates.. Drugs and Alcohol Findings, 2001; 5: 4 18.. Joint EMCDDA and ECDC Rapid Risk Assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania.. Portugal/Sweden: European Monitoring Centre for Drugs and Drug Addiction European Centre for Disease Prevention and Control; 2012.. Drug Strategy 2010: Reducing Demand, Restricting Supply, Building Recovery:Supporting People to Live a Drug Free Life.. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N Ford C.. Comorbidity of Substance Misuse and Mental Illness in Community Mental Health and Substance Misuse Services.. British Journal of Psychiatry, 2003; 183: 304 313.. HallW FarrellM.. Comorbidity of Mental Disorders with Substance Misuse.. British Journal of Psychiatry, 1997; 171: 4 5.. Ward J, Mattick RP, Hall W.. The Effectiveness of Methadone Maintenance Treatment: An Overview.. Drug and Alcohol Review, 2009; 13: 327 336.. TurnerKME, Hutchinson S, Vickerman P, HopeV, CraineN, et al.. The impact of needle and syringe provision andopiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.. Addiction, 2011; 106(11): 1978 1988.. Mattick RP, Breen C, Kimber J Davoli M.. Successful Strategies in Addressing Opioid Overdose Deaths.. Rockville, MD: Center for Substance Abuse Treatment, 2010.. Zanis DA Woody GE.. One-year Mortality Rates Following Methadone Treatment Discharge.. Drug and Alcohol Dependence, 1998; 52: 257 260.. Lind B, Chen S, Weatherburn D, Mattick R.. The Effectiveness of Methadone Maintenance Treatment in Controlling Crime: An Australian Aggregate-Level Analysis.. Journal of Criminology, 2005; 45: 201 211.. Turnbull PJ, Edmunds M Hough M.. Drug Treatment and Testing Orders: Final Evaluation Report.. London: Home Office Research, Development and Statistics Directorate, 2000.. Powers KI Anglin MD.. Cumulative Versus Stabilizing Effects of Methadone Maintenance: A Quasi-ExperimentalStudy Using Longitudinal Self-Report Data.. Evaluation Review, 1993;17:243 270.. Injectable Heroin (and Injectable Methadone): Potential Roles in Drug Treatment: Full Guidance Report.. London: National Treatment Agency for Substance Misuse, 2003.. Jones A, Donmall M, Millar T, Moody A, Weston S, Anderson T, Gittins M, Abeywardana V D Souza J.. The Drug Treatment Outcomes Research Study (DTORS): Final Outcomes Report.. London: Home Office, 2009.. Condelli WS.. Strategies for Increasing Retention in Methadone Programs.. Journal of Psychoactive Drugs, 1993; 25: 143 147.. McGlothlin WH Anglin MD.. Shutting Off Methadone: Costs and Benefits.. Archives of General Psychiatry, 1981; 38(8):885-892.. Anglin MD, Speckart GR, Booth MW Ryan TM.. Consequences and Costs of Shutting Off Methadone.. Addictive Behaviors, 1989; 14(3):307-326.. Caplehorn JR.. A Comparison of Abstinence-Oriented and Indefinite Methadone Maintenance Treatment.. International Journal of the Addictions, 1994; 29(11):1361-75.. Statistics from the National Drug Treatment Monitoring System (NDTMS) 1 April 2010 31 March 2011: Volume 1: The Numbers.. London: Department of Health, National Treatment Agency for Substance Misuse Office of National Statistics; 2011.. Mayet S, Farrell M, Ferri M, Amato L Davoli M.. Psychosocial Treatment for Opiate Abuse and Dependence.. Cochrane Database of Systematic Reviews, 2010; Issue 4: CD004330.. Cumulative Versus Stabilizing Effects of Methadone Maintenance: A Quasi-Experimental Study Using Longitudinal Self-Report Data.. Evaluation Review, 1993; 17: 243 270.. Drug Treatment in England: The Road to Recovery.. London: National Treatment Agency for Substance Misuse; 2012.. Return on Investment 2: Evaluating the Cost-Effectiveness of Needle and Syringe Programs inAustralia.. Sydney:Australian Government, Department of Health and Ageing, National Centrein HIV Epidemiology and Clinical Research, 2009..

    Original link path: /putting_public_health_first/index.html
    Open archive
  •  

  • Title: 'Putting Full Recovery First' Views of UK service users and providers
    Descriptive info: 'Putting Full Recovery First'.. Views of UK service users and providers.. Download the document as a pdf.. In 2010, the Coalition Government released its new Drug Strategy, with a focus on recovery.. In March 2012, the Government issued a new document entitled Putting Full Recovery First.. This is described in the document as:.. the Government's roadmap for building a new treatment system based on recovery.. The Home Office describes it as the Recovery Roadmap.. A survey of over 500 UK drug service users and providers by the UK Harm Reduction Alliance, the National Users Network and the UK Recovery Federation shows:.. Lack of consultation on Coalition Government s Recovery Roadmap.. Disagreement with the Government that Payment by Results (PbR) and the Recovery Roadmap will mean better value for money; and a fear about cuts in funding for drug services.. Disagreement with Coalition s focus on removing people from Opioid Substitution Therapy (e.. g.. methadone) and fear about harm to people currently benefitting from substitute medications.. Lack of trust in Coalition s ability to deliver on reducing drug related deaths, blood borne viruses (including HIV), and on improving outcomes for people experiencing drug dependence problems.. The results are summarised below the full results are available at.. http://tinyurl.. com/bvd3ef3.. Respondents.. The survey was distributed through UK harm reduction and recovery networks, websites, and social media and advertised on DrugScope s news alert, DS Daily.. 540 people took the survey 396 completed all questions.. Respondents included 126 key workers, 50 service managers and 115 people who use drugs - either in services (76) or not currently using services (39).. 67% of all respondents were  ...   services while almost 75% had already witnessed cuts.. According to the Recovery Roadmap there is a need to bring an urgent end to the current drift of far too many people into indefinite maintenance, which is a replacement of one dependency with another.. Over 50% of respondents disagreed with this statement while 43.. 5% agreed.. Despite this apparent split in opinion, over 80% disagreed with the Government that recovery should mean abstinence from any chemical including prescribed substitution medications such as methadone.. Over 80% also disagreed that this concept of recovery should form the basis of Payment by Results as stated in the Recovery Roadmap.. Almost 65% felt the Roadmap would have a negative impact on people receiving OST medications.. Less than 10% saw the Recovery Roadmap as being based on the best scientific evidence.. The Recovery Roadmap states that it will deliver on reducing blood borne viruses and drug related deaths while improving outcomes for people experiencing drug dependence problems.. 58% of respondents disagreed that the Roadmap would lead to improved care for people who use drugs (22.. 6% agreed).. 64% disagreed that the Roadmap would help to reduce drug related deaths, and 60% disagreed with the assertion that It is self-evident that the best protection against blood borne viruses is full recovery.. While 83% agreed with the Roadmap s contention that [I]n the past, positive treatment outcomes have been undermined and eroded by a failure to secure stable accommodation or sustained employment only 20% were of the view that the Roadmap s approach would have a positive impact on access to housing and jobs for people who use drugs..

    Original link path: /putting_public_health_first/survey_results/index.html
    Open archive

  • Title: Reducing Injecting Related Harm: Consensus Statement on Best Practice
    Descriptive info: Reducing Injecting Related Harm:.. Consensus Statement on Best Practice.. A consensus best practice statement has been published by the.. , UK Harm Reduction Alliance and.. Exchange Supplies.. in response to the increasing numbers of requests for a document to set out the principles by which needle and syringe supply should be organised.. We submitted it to the NTA in October 2006 as part of their review of harm reduction with a recommendation that they publish it, or something like it in order to ensure that there is no doubt in the minds of comissioners or providers as to what constitutes good (and bad) practice.. To download the consensus statement,.. Reducing Injecting Related Harm: Consensus Statement on Best Practice.. Provision of sterile injecting equipment, as part of a broader harm reduction approach that includes other interventions such as substitute prescribing, are a vital element in preventing blood borne virus transmission amongst injecting drug users.. Over 200 studies, conducted around the world, were reviewed by the World Health Organisation, in 2004.. The conclusion of the review was that there is compelling evidence that increasing availability of injecting equipment reduces transmission of human immunodeficiency virus (HIV).. This review, and other studies, have also found that increasing injecting equipment supply through syringe exchange and other means:.. reduces hepatitis B virus, hepatitis C virus and other blood borne pathogens among injecting drug users;.. reduce the number of used needles discarded in the community;.. do not encourage injecting drug use;.. do not increase the duration or frequency of injecting;.. do not decrease motivation to reduce drug use;.. are cost effective, and deliver substantial savings in HIV treatment;.. and.. are often the only contact injecting drug users have with health and social service providers.. Early introduction of needle exchange in the UK averted an HIV epidemic.. However, hepatitis C was already endemic amongst injecting drug users when needle exchange was introduced, and incidence (the number of people who catch the virus) and prevalence (the number of people with) of hepatitis C has remained high.. There is evidence that HIV incidence and prevalence is rising.. In order to reduce transmission of these viruses, we must work to increase supply, and reduce sharing of syringes and other items associated with the risk of blood borne virus transmission.. Essential service  ...   need for themselves.. and the people they inject with;.. not place limits on the amounts of injecting equipment people can take away; and.. not routinely limit distribution of equipment to those who do not bring back.. used equipment.. References.. 1 World Health Organisation.. Policy Brief: Provision of sterile injecting equipment to reduce HIV transmission.. Geneva: 2004 Accessible via:.. www.. who.. int/hiv/pub/advocacy/en/provisionofsterileen.. 2 MacDonald M.. et al.. Effectiveness of needle and syringe programmes for preventing HIV transmission.. International Journal of Drug Policy: 2003, 14(5 6), p.. 353 357.. American Journal of Public Health.. Dec; 89(12): 1852 4.. 3 Gibson DR, Brand R, Anderson K, Kahn JC, Perales D, Guydish J.. Two- to sixfold decreased odds of HIV risk behaviour associated with use of syringe exchange.. Journal of Acquired Immune Deficiency Syndromes, 2002; 31: 237 242.. 4 Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ.. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.. American Journal of Public Health, 1995; 85(11): 1531 1537.. 5 Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D: The effect of a needle exchange program on numbers of discarded needles: A 2-year follow-up.. American Journal of Public Health 2000, 90: 936 939.. 6 Stimson G V, Alldritt L J, Dolan K A, et al.. (November 1988) Injecting Equipment Exchange Schemes Final Report.. Monitoring Research Group, University of London, Goldsmiths College.. 7 Health Outcomes International Pty Ltd in association with the National Centre for HIV Epidemiology and Clinical Research and Professor Michael Drummond, Centre of Health Economics, York University.. Return on investment in needle and syringe programs in Australia.. Australian Commonwealth Department of Health and Ageing, 2002.. 8 Robertson J R, Bucknall A B V, Welsby P D et al (1986) An epidemic of AIDS-related virus (HTLV lll/ LAV) infection among intravenous drug abusers in a Scottish general practice.. British Medical Journal, 292: 527 30.. 9 Ashton M.. Hepatitis C and needle exchange: part 1 the dimensions of the challenge Drug and Alcohol Findings: 20.. 10 Judd A, Hickman M, Jones S et al.. (2004) Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study.. BMJ, doi:10.. 1136/bmj.. 38286.. 841227.. 7c (published 12 November 2004).. |..

    Original link path: /statements/consensus_statement_on_best_practice.html
    Open archive

  • Title: UKHRA statement: Consultation Response: 2010 Drug Strategy
    Descriptive info: Consultation Response: 2010 Drug Strategy.. To download the responseas a pdf,.. KEY POINTS:.. The adoption of harm reduction approaches by the Conservative government in the 1980s has been an overwhelming public health success.. Any response which emphasises drug-free outcomes for individuals must also acknowledge and reduce the harms faced by those who are unable or unwilling to stop using drugs.. There is strong national and international evidence of effectiveness and cost-effectiveness for interventions such as needle and syringe programmes, opioid substitution therapy and overdose prevention.. Harm reduction therefore warrants inclusion as an explicit priority in the new Drug Strategy.. ABOUT UKHRA.. The UK Harm Reduction Alliance (UKHRA) is coalition of health and social care workers, criminal justice workers, academics, advocates and people who use drugs.. It was founded in 2000 with the aim of ensuring that public health and human rights remain at the centre of drug treatment and services.. Our work involves campaigns, publications, e-lists for drug workers and people who use drugs, and input into national policy consultations and discussions in order to support harm reduction and promote the evidence base.. ABOUT NNEF.. The National Needle Exchange Forum (NNEF) is a forum for workers involved in harm reduction services across England.. It was founded in the 1980s to actively promote and support the provision of high quality, comprehensive needle and syringe programmes (NSPs) as a key part of the UK Drug Strategy.. The NNEF works with policy makers and a range of partners to identify and promote good practice through regular meetings and research.. In keeping with the expertise of these organisations, this response will focus only on the questions in the consultation that are relevant to harm reduction services and how they are delivered in the UK.. GENERAL REMARKS.. UKHRA and NNEF both welcome the government plans to publish a new drug strategy.. Following the previous UK consultation ( Drugs: Our Community, Your Say in 2007), there was a strong sense in the harm reduction field that the resulting policy Drugs: Protecting Families and Communities failed to build upon major lessons from the past and was insufficient (despite the welcome emphasis on treatment quality, families and communities).. Harm reduction in particular was massively under-represented in the final document despite the overwhelming public health success of this approach in the UK and the strength of national and international evidence.. This consultation is an opportunity for the new government to adopt a more considered approach and achieve its aims of taking a broad approach to preventing and reducing substance misuse.. Given its aims, the overall content and underlying themes of this consultation document are, however, disappointing.. The reduction of drug-related harm is only referred to twice in the entire text and harm reduction is not mentioned once.. There is no information about the process by which themes, priorities and questions were selected, and the language used appears to disregard harm reduction and the crucial role that it has played (and must continue to play) in the UK.. Instead, terms such as enforcement , prevention , rebalancing and drug free outcomes are repeatedly emphasised.. These are important elements of a comprehensive strategy, but ones that will be compromised if attention is not also paid to the immediate harms faced by those who continue to use drugs, their families and communities.. The consultation under-emphasises the need for proven and effective harm reduction interventions to protect people who will not or cannot become drug free in the immediate future.. UKHRA and NNEF hope that this joint response will help to re-state the case for harm reduction and ensure its inclusion in the strategy as a platform for improving treatment outcomes.. VISION FOR THE NEW DRUG STRATEGY.. The consultation opens by stating that The Home Office will lead the new Drug Strategy to prevent drug taking, disrupt drug supply, strengthen enforcement and promote drug treatment.. UKHRA and NNEF strongly believe that the Drug Strategy should be the mandate of the Department of Health or, at least, an equal partnership between this body and the Home Office.. Drug use is primarily a public health issue and framing it this way allows for more pragmatic, rights-based, evidence-informed and cost-effective responses.. A1: Are there other key aspects of reducing drug use that you feel should be addressed?.. Yes.. Harm reduction should be one of the primary, explicit aims and priorities for the Drug Strategy in recognition of the existing clinical, social and scientific evidence for its effectiveness, cost-effectiveness and impact.. Harm reduction can be defined as Policies, programs and practices that aim primarily to reduce the adverse health, social and economic consequences of the use of legal and illegal psychoactive drugs without necessarily reducing drug consumption.. The evidence for this approach has been building since the 1980s and has developed from small-scale pilots and trials, to larger national studies and evaluations, to international research, to reviews of this research, and most recently to reviews of these reviews.. In 2009, after several such comprehensive assessments, the UN formally approved a comprehensive package of nine interventions for the prevention, treatment and care of HIV among people who inject drugs.. This includes needle and syringe programmes (NSPs), opioid substitution therapy (OST), condom distribution, HIV testing and treatment, and vaccination, testing and treatment for hepatitis and tuberculosis.. According to the UN guide and the available evidence, these are the interventions with the best evidence in community, prison and outreach settings.. A3: What do you think has worked well in previous approaches to tackling drug misuse?.. Since its incorporation into UK policy by the Conservative Government in the mid-1980s, harm reduction has been an unequivocal public health success.. Compared to many other countries, HIV prevalence among people who inject drugs in the UK has remained low.. In 2008, only around one in 73 people who inject drugs in the UK were living with HIV.. In comparable countries which were slower to adopt harm reduction such as Italy, Russia, Spain and the USA the figure is between six and sixteen times higher than in the UK.. Since its adoption, the UK s harm reduction responses have been widely regarded as best practice around the world.. Interventions such as NSP and OST have become well established in the UK and the evidence of their effectiveness and cost-effectiveness has grown accordingly (see below).. It is crucial that this progress is not undone after more than two decades of success.. Experience from cities around the world has shown that HIV prevalence among people who inject drugs can reach 40% in just two years in the absence of effective responses.. This would have catastrophic financial, political, health and social consequences for the UK.. A4: What do you think has not worked so well in previous approaches to tackling drug misuse?.. The continued focus on enforcement and criminal justice has not reduced drug use despite the significant cost of this approach.. The Misuse of Drugs Act (1971) predates the HIV epidemic and is in urgent need of review.. This will require strength of leadership from this government that has been lacking in recent years (as evidenced by the Home Office s recent suppression of an impact analysis on the Act.. Previous governments have often ignored scientific evidence and independent, expert advice from the ACMD on a range of drug-related issues.. One example was the dismissal of evidence on the effectiveness of supervised injecting facilities in 2006.. The future strategy needs to be better informed by evidence and should also encourage research and debate.. STRENGTHENING ENFORCEMENT, CRIMINAL JUSTICE AND LEGAL FRAMEWORK.. C3: Do you have a view on what factors the Government should take into consideration when  ...   seeking help with their drug use, it is an important part of the treatment journey for thousands of people who might ultimately seek drug-free recovery.. As such, it must remain a core element of the UK Drug Strategy on the basis of maintenance or reduction depending on the wishes and needs of the patient him/herself (identified through comprehensive assessment based on the guidance which already exists within the UK.. Individual choices regarding OST must not be made by national policy through arbitrary limits on treatment length or dose - nor should OST be the only option available to any client.. Heroin Prescribing.. In recent years, a number of small but important trials have taken place in the UK, such as the Randomised Injecting Opioid Treatment Trial (RIOTT) that compares the effectiveness of injectable medicinal heroin and injectable methadone among 127 long-term heroin users for whom other OST interventions have failed.. Based on the positive findings of this study, UKHRA and NNEF would like to see the new Drug Strategy support this intervention.. A Cochrane review in 2005 concluded that heroin-assisted treatment - as an intervention for long-term drug users who have repeatedly failed with other OST approaches - can increase retention in treatment and reduce drug use and imprisonment.. Overdose Prevention.. Drug overdoses remain a major, but overlooked, harm for people who use drugs across the UK.. As release from prison.. and relapse after drug-free treatment.. are known risks for overdoses, it is essential that the Drug Strategy seeks to prevent this harm if it chooses to emphasise criminal justice approaches and abstinence-based interventions.. People who use drugs, their families and friends should be educated in overdose prevention and how to respond.. For opiate users, a cure exists in the form of naloxone the widespread provision of which is practiced in many countries and backed by numerous studies.. With results due from the NTA pilots of naloxone distribution, UKHRA and NNEF strongly recommend the inclusion of this life-saving and inexpensive intervention in the new Drug Strategy.. In 2008, there were reported to be 1,617 deaths related to drug misuse in England.. - many of which could have been prevented.. Reductions in drug mortality should be a major indicator for success for UK drug policy: people cannot recover from problem drug use if they are dead.. User Involvement.. The UK has made great strides toward empowering and engaging current and former drug users in policy, planning and implementation.. The opinions and expertise of these groups are essential to the success of interventions to reduce harm and tackle drug use.. As such, user involvement should be explicitly supported and valued in the new Drug Strategy, not least because it can dramatically increase programme effectiveness.. D7: We want to ensure that we continue to build the skills of the drug treatment and rehabilitation sector to ensure that they are able to meet the needs of those seeking treatment.. What more can we do to support this?.. The government is in an enviable position it already has a highly skilled and committed workforce in the drug field.. The roll-out of Drug and Alcohol National Occupational Standards (DANOS) has helped ensure that all workers, regardless of their background, work with common core competencies and principles.. For the past ten years, these professionals have worked with their clients to deliver a comprehensive treatment package.. The government does not need to build a skilled workforce, it just needs to invest in further developing the existing workforce.. As part of a comprehensive menu of interventions, workers in all areas of drug treatment and harm reduction must be better supported to attend training, learn skills, engage in policy discussions, work in collaboration with one another and learn from (and share) good practice and new research (i.. through networking events and conferences).. By fostering partnerships, the government can bring the best out of its existing workforce.. D9: How do you believe that commissioners should be held to account for ensuring that outcomes of community-based treatments, for the promotion of reintegration and recovery, as well as reduced health harms, are delivered?.. A survey of NSPs by the National Treatment Agency in 2005.. reported a mixed economy in terms of the equipment and services provided.. Nearly half of the responding services did not provide condoms.. In addition, more than half did not provide acidifiers, filters, mixing cookers or sterile water - which are essential items for injecting and are approved by UK paraphernalia law.. Further, a survey by the National Needle Exchange Forum in 2008 found that only 15% of respondents were providing aluminium foil to clients to promote safer non-injecting methods of drug use.. (an intervention backed by evidence.. The new Drug Strategy should include measures to prevent a postcode lottery of services.. For example, it could establish an evidence-informed core package of interventions that each local authority must provide (whilst taking care not to hinder local innovations and developments).. This will help to improve service quality and ensure that harm reduction remains a key component of the government s broad approach to preventing and reducing substance misuse.. All references retrieved 28/09/2010.. For further information or discussion, please contact:.. Jamie Bridge, for UKHRA bridgejamie@hotmail.. Helen Wilks, Co-Chair, NNEF.. See, for example,.. antidrug.. health.. am/eng/lib_eng/HR_Hunt.. ihra.. net/files/2010/08/10/Briefing_What_is_HR_English.. pdf.. int/hiv/pub/idu/idu_target_setting_guide.. int/hiv/pub/idu/evidence_for_action/en/index.. AIDS and injecting drug use in the United Kingdom, 1987-1993: the policy response and the prevention of the epidemic.. Social Science and Medicine.. , 1995; 41(5): 699-716.. (Abstract:.. ncbi.. nlm.. nih.. gov/pubmed/7502102.. hpa.. uk/web/HPAwebFile/HPAweb_C/1254510653792.. Mathers B et al.. The global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.. The Lancet.. , 2008; 372(9651): 1733-1745.. gov/pubmed/18817968.. ).. Stimson G Choopanya K.. Global perspectives on drug injecting.. In: Stimson G et al (eds).. Drug Injecting and HIV Infection.. London: UCL Press, 1998.. bbc.. co.. uk/blogs/opensecrets/2010/06/home_office_error_reveals_how_foi_request_handled.. html?page=9.. jrf.. uk/sites/files/jrf/9781859354711.. Lenton S Single E.. Drug and Alcohol Review.. , 1998; 17(2): 213-220.. nice.. uk/nicemedia/live/12130/43301/43301.. Degenhardt L et al.. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.. , 2010; 376: 285 301.. gov/pubmed/20650522.. MacDonald M et al.. International Journal of Drug Policy.. ,2003; 14: 353 357.. ijdp.. org/article/S0955-3959(03)00133-6/abstract.. int/hiv/pub/prev_care/effectivenesssterileneedle.. http://whqlibdoc.. int/hq/2004/WHO_HIV_2004.. 03.. int/publications/2007/9789241596190_eng.. nta.. nhs.. uk/uploads/clinical_guidelines_2007.. uk/nicemedia/pdf/TA114Niceguidance.. int/substance_abuse/publications/Opioid_dependence_guidelines.. int/medicines/publications/essentialmedicines/Updated_sixteenth_adult_list_en.. Ball JC Ross A.. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcomes.. New York: Springer-Verlag, 1991.. Ward J et al.. Methadone Maintenance Treatment and Other Opioid Replacement Therapies.. Amsterdam: Harwood, 1998.. nap.. edu/openbook.. php?record_id=1551 page=R1.. Advisory Council on the Misuse of Drugs.. AIDS and Drug Misuse Update Report.. London: HMSO, 1993.. gov/pmc/articles/PMC2541312/pdf/bmj00461-0035.. Marsch LA.. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis.. Addiction.. , 1998; 93(4): 515-532.. gov/pubmed/9684390.. Amato L et al.. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.. Journal of Substance Abuse Treatment.. , 2005; 28(4): 321-329.. gov/pubmed/15925266.. Mattick RP et al.. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.. Cochrane Database of Systematic Reviews.. , 2009.. http://www2.. cochrane.. org/reviews/en/ab002209.. int/hiv/pub/idu/drugdependence_final.. Strang J et al.. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.. , 2010; 375(9729): 1885-1895.. gov/pubmed/20511018.. Ferri M et al.. Heroin maintenance for chronic heroin dependents.. , 2005.. org/reviews/en/ab003410.. Farrell M Marsden J.. Acute risk of drug-related death among newly released prisoners in England and Wales.. , 2008; 103(2): 251 255.. gov/pubmed/18199304.. bmj.. com/content/326/7396/959.. full.. harmreductionjournal.. com/content/pdf/1477-7517-6-26.. net/contents/717.. uk/uploads/number_of_deaths_related_to_drug_misuse_by_gender_in_england_1993_2008.. emcdda.. europa.. eu/attachements.. cfm/att_101264_EN_emcdda-harm%20red-mon-ch12-web.. uk/uploads/nta_nes1_needle_exchange_survey.. legislation.. gov.. uk/uksi/2003/1653/regulation/2/made.. http://nnef.. uk/nnef_statements/resources/2009-03_NNEF_Survey_Report_ACMD_TC.. com/content/pdf/1477-7517-5-24..

    Original link path: /statements/drug-strategy-response.html
    Open archive

  • Title: UKHRA discussion group - nettiquette
    Descriptive info: UKHRA discussion list nettiquette.. List culture.. Posting.. Off-list messages to individuals.. Replying to messages.. Confidentiality.. Policing the list.. The digest facility.. Joining, leaving and changing address.. UKHRA discussion exists to facilitate the sharing of information and views and for debate and discussion of harm reduction issues.. This statement on list etiquette was agreed by the group in September 2004, and is posted on the website as a guide for new or prospective members and as a reminder for the group.. If you are new to the internet, or have trouble joining the UKHRA lists,.. It is hoped that contributions by members of UKHRA discussion will always be polite, will always seek to address issues and ideas rather than individuals, and will always seek to carry discussions forward.. Normal rules of civil social interaction should apply to all postings the translation of thoughts to the written, rather than spoken, word and the remoteness of the recipients should not be used as an excuse to communicate in an anti-social manner.. Barriers to communication such as person-to-person aggression, deviation from the spirit of a topic, excessive use of jargon or banter in an otherwise serious topic, should all be avoided.. When you hit the send button your message will go to the 200+ members of the list.. Members (particularly regular posters) should bear this in mind before they hit send so as to avoid cluttering the list with unnecessary messages, but the list positively welcomes new members and encourages them to start new discussions because the list exists to answer questions and debate issues.. It should be assumed that individuals post messages to the list because they want public discussion not a private conversation.. If senders don't want public responses they should say so in their message.. If senders want off-list responses, their message should give an indication of how they will deal with them (e.. by posting a summary of replies back to the list).. BE GENEROUS WITH YOUR IDEAS and give new information.. A simple message 'I agree' only gives information about yourself.. If you have further ideas say so.. Messages that begin 'I agree with that message because.. ' or 'I disagree with that message because.. ' are much more likely to lead to useful discussion.. PRIVATE AGENDAS: For the same kinds of reason please don't quote off-list messages in your postings to the list.. Such quotes discourage open discussion because they will not be understandable to members not in the know, and because they give the impression the real agenda is being pursued elsewhere.. DON'T BE AFRAID TO STICK YOUR NECK OUT: If you express yourself in too extreme a form you can graciously moderate your position in some later message in the light of the discussion.. If you display ignorance there are plenty of members who can put you right, but this should be done in a spirit of generosity and understanding.. Should only ever be of a supportive or informative nature.. Sending emails containing language or sentiments that would not be appropriate for the list direct to people can be very intimidating and is therefore not acceptable, and can be reported to the list moderators who will  ...   quicker.. You should make sure that your email software is set to compose messages in plain ASCII text.. If you use Outlook Express go to Edit/Preferences/Message Composition/Mail Sending Format to make sure that Plain Text is ticked.. In Outlook go to Tools/Options/Mail Format to check that you are sending Plain Text.. Anyone can join the list and membership is not monitored or moderated - many members of the list follow the discussions but do not post and this should be borne in mind by members.. By joining the list you agree to maintain confidentiality of members and respect their right not to have postings forwarded or copied off list without express permission (this can be requested on or off list).. The list usually polices itself effectively and no one (other than unsolicited advertisers who have never contributed before) has ever been removed from the group.. This is because to unnecessarily interfere with discussion could unreasonably restrict the flow of debate, and because we recognise that it is impossible to exclude anyone from the list who really wants to be there - all they would need to do is re-register under a new name with a new hotmail address.. This possibility makes exclusion rather a symbolic act.. As a general rule it would be unreasonable and unrealistic for UKHRA to exclude list members on the basis of expressed opinions, at least where these opinions are not outside the law.. A policy that attempts to exclude people on the basis of offensive or distasteful remarks would probably be unwelcome, unworkable and unfair.. There are however, limited circumstances where we feel it could be appropriate to exclude people.. These would include sending vitriolic abuse (on or off list) to other list members and posting unsolicited advertising.. In the case of unsolicited advertising, particularly of products unrelated to harm reduction, removal will be instant.. If any list members have experienced abusive emails off list as a direct result of their participation in this forum and would like support around this, we would urge you to contact any member of the committee (.. to go to a page with email addresses for all committee members).. Removal from the list will only be done when both moderators have agreed.. Members who feel they have been unjustly removed may appeal to the chair of ukhra and request that the decision be reviewed by the committee.. The digest facility:.. UKHRA discussion has a digest facility that supports the posting of list messages only once a day.. To use this you should go to the yahoo website.. com/group/ukhra-discussion/.. and go to my groups edit my membership.. But if you are replying to a message from a digest please alter the subject line to maintain coherence in the discussion.. The subject line should be altered to the subject line of the specific message you are referring to.. ATTACHMENTS: do not send attachments to the list as yahoo will filter them out because attachments are the most common way in which viruses spread.. Are all easy to do by going to the yahoo groups site:.. For UKHRA discussion go to:.. For UKHRA needle exchange discussion go to:.. http://health.. groups.. com/group/needle-X-discussion/.. |..

    Original link path: /nettiquette.html
    Open archive

  • Title: Help joining the UKHRA Groups
    Descriptive info: Help joining the UKHRA Groups.. The UKHRA discussion lists use a free service offered by Yahoo, known as 'Yahoo Groups'.. So to join the list you first have to have a Yahoo account.. It is free and easy (usually) to join Yahoo, but if you are  ...   groups we have a couple of members who have volunteered to help people through the signing up process.. To request help please send an email to:.. nigelhelpmejoin@ukhra.. or.. davidhelpmejoin@ukhra.. Before you sign up it's worth reading the information on the 'rules' for posting - to see it,..

    Original link path: /joining_yahoo.html
    Open archive

  • Title: UKHRA - What's new?
    Descriptive info: What's new?.. Regular visitors to the site will probably want to come to this page first: we'll post a report on this page everytime we update the site.. To see the joint UKHRA/NNEF response to the Coalition's drug strategy,.. (06/10/10).. An excellent.. sample drugs policy.. and accompanying guidance for accommodation.. services specifically designed to work with drug or alcohol users posted.. For more details,.. (23/04/08).. Minutes of the 2007 AGM posted.. To read/download them,.. (15/1/08).. Accounts for the year to 31/03/2007.. posted to the website.. To download them,.. (19/11/07).. Minutes of 2006 AGM.. posted.. (16/01/06).. Powerpoint presentation by Danny Morris, UKHRA, to.. Annual Drug and.. Alcohol Professionals Conference 2006 (FDAP).. , London, November 8th 2006.. To view,.. (18/12/06).. UKHRA.. have published a.. consensus statement.. with the.. and.. defining best practice in needle exchange.. To read it,.. (07/11/06).. Agenda for.. 2006 AGM.. (02/11/06).. Accounts for the year to 31/03/2006.. :.. Many responses to drug use have been defined at some time as 'harm reduction', and this has led to confusion as to what harm reduction actually is.. In order to clarify the situation, UKHRA the UK's leading organisation campaigning for a rational, harm reduction oriented response to drug use has prepared a definition of harm reduction, and identified the core principles of harm reduction.. Link to Department of Health guidance document posted.. This Dept.. of Health guidance gives potentially important guidance that may enable proper payment to be made for service user involvement without jeopardising people's benefits.. Among other things, it describes how these issues should be addressed with Jobcentre Plus and the Inland Revenue.. Form more information.. (20/04/06).. For diverse reasons, Northern Ireland's drug services are seriously out of step with many aspects of good practice now taken for granted elsewhere in the UK.. Northern Ireland's Department of Health, Social services and Public Safety have recently consulted on its draft "New Strategic Direction for Alcohol and Drugs 2006-2011" (.. dhsspsni.. uk/showconsultations?txtid=13814.. To read UKHRA's response,.. (31/03/06).. Powerpoint presentation by UKHRA Chair, Neil Hunt on.. 'Needle exchange and.. opioid substitution treatment in UK prisons'.. , posted.. to view,.. (20/02/06).. Minutes of the 2005 AGM posted.. (19/12/05).. New UKHRA.. committee list.. (7/12/05).. New page added to.. help people join the UKHRA discussion lists.. To see it,.. (28/11/05).. Paying for user involvment:.. 2 word documents posted for download with practical solutions for those wanting to effectively engage service users in all aspects of service design, development and delivery.. (21/11/05).. The Annual General Meeting (AGM).. of UKHRA Limited will be held at.. The Resource Centre.. , London, on.. Friday 2nd December 2005.. (14/11/05).. UKHRA accounts.. for the year to 31st March 2005 posted.. To view them or download (as pdf).. (17/9/05).. UKHRA calls for urgent action to end the shortage of injectable diamorphine.. that is causing serious hardship and risking the lives of drug users whose treatment has been stopped or changed.. To read the full statement and download a Word version of the document,.. (14/9/05).. stakeholder questionnaire survey.. posted as pdf download.. Click here.. to download the findings (30/7/05).. The National Treatment Agency for substance misuse.. is conducting a survey to find out how users feel about the treatment they are receiving and the services they attend.. Banner linking to NTA webpage.. posted on home page.. (29/7/05).. Des Flanagan.. , manager of Railway Street Addiction Service in Ballymena Northern Ireland and.. UKHRA vice-chair.. was presented with the.. National Rolleston Award.. at the 16th International conference on the Reduction of Drug Related Harm, held in Belfast in March 2005.. For more details.. (11/4/05).. 4th Tom Waller Award.. presented to Ian Smith.. for more information (29/3/05).. Links to the.. Compass.. NNEF.. (National Needle Exchange Forum) websites added to the UKHRA.. links page.. (14/3/05).. US pressure to silence United Nations support for harm reduction and needle exchange - response update,.. (3/3/05).. US pressure to silence United Nations support for harm reduction and needle exchange.. For full infromation on this issue, and an open letter from Gerry Stimson of the International Harm Reduction Association to delegates of the Forty-eighth session of the Commission on Narcotic Drugs (CND),.. (13/2/05).. Blood borne viruses and needle and syringe provision.. UKHRA has mailed a copy of an important recent paper published in the British Medical Journal:.. 'Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study'.. to over 3000 agencies throughout the UK.. For more details and to download/read the paper,.. (7/2/05).. Link to the.. DrinkandDrugs.. Net.. site added to the UKHRA.. (29/1/05).. AIDSmeds.. (17/1/05).. UKRHA position statement on  ...   have used heroin in the last 6 months.. (16/2/04).. Practice development: Health Protection Agency report.. 'Shooting Up'.. on blood borne virus transmission amongst injectors posted (24/1/04).. Open meeting in Belfast on 16th March 2004.. announced (12/1/04).. New section to allow harm reductionists to share useful documents launched.. First posting is a.. policy and protocol for needle exchange.. in police custody (4/11/03).. Danish drug users union.. (bi-lingual) site added (7/10/03).. Jon Derricott elected Chair and Desmond Flannagan Vice Chair.. To see the full committee list please.. (20/9/03).. Minutes of 2003 AGM posted.. To read them.. (20/8/03).. UKHRA response to the Home Office Public Consultation: Computer Generated Prescriptions, Registers and Requisitions for Controlled Drugs.. To read this,.. Details posted of committee meetings planned for 2003/4.. to see the list (31/7/03).. List of the new committee members posted.. to see the list (23/7/03).. Details of the 2003 AGM posted,.. for more details (5/7/03).. 'Stop the Murder of Thai Drug Users' latest information posted with a link to the Lifeline website.. Please.. for more details (20/5/03).. Tom Waller Award page added - to find out about the award, and to nominate someone for it,.. (14/5/03).. A couple of articles from the archive added: the speech from Gerry Stimson which got the ball rolling and led to the formation of UKHRA, and the original declaration of principle drawn up after a meeting in Manchester in August 2000.. To read the article,.. To read the original declaration of principle,.. (7/5/03).. UKHRA is helping co-ordinate a day of action on the 12th June to protest at the killing of Thai drug users, to find out more about the planned actions, please.. (1/5/03).. Information on an international day of action in support of Thai drug users posted on the site.. (23/4/03).. Latest update on UKHRA conference 13th June:.. New additional speaker - Commander Brian Paddick (Specialist Crime Directorate New Scotland Yard) will give a presentation entitled 'The police approach to drugs.. Have they got it right?'.. for conference information (18/4/03).. DanceSafe.. org added to the.. (9/4/03).. Patricia Hewitt indicates that the government will turn down OFT proposal to deregulate community pharmacies, to read the ukhra response to this proposal (which threatened needle exchange and methadone dispensing).. , to read the story on Patricia Hewitt's rejection of the OFT proposals,.. (7/4/03).. Information on the ukhra users mailing list added.. for more details (3/4/03).. for new information on the elections to the committee and who is standing.. down/seeking re-election (25/3/03).. Details of the UKHRA 3rd Annual Conference (13th June 2003, The Cardiff Convention Centre, Wales) are available for download in pdf format.. for more details (14/3/03).. UKHRA has responded to the Department of Health on the Office of Fair Trading report which recommended increased competition and freedom for supermarkets to be able to provide pharmacy services.. We believe that this could have a negative impact on needle and syringe provision and methadone dispensing.. To read the full text of our response,.. (11/3/03).. UKHRA response to the home office consultation on reform of section 9a of the misuse of drugs act available on line.. To download the word file,.. (13/2/03).. '.. The 5th Amendment' now available as a pdf file (384KB).. To download,.. (10/2/03).. Health and Law Foundation (healthandlaw.. org) - a site giving details of the huge problems caused by General Medical Council action against private doctors - added to the.. (26/1/03).. Social Science Information Gateway site added to the.. (22/1/03).. UKHRA annual conference 2003 dates and venue announced.. for details.. (20/1/03).. Information about UKHRA constitution and committee posted up.. To see who is on the committee, and to find out more about how you could stand,.. Join the UKHRA discussion group on young people and drugs - link to this interesting, low-traffic, discussion group added to the site.. If you'd like to join,.. (18/12/02).. UKHRA '5th Amendment' posted.. In 2002 UKHRA tried to influence the drafting of the new drugs strategy by proposing a public health aim.. The full text of the proposal is now online.. (17/12/02).. UKHRA response to the Hep C strategy now online.. New section added to the site which will contain UKHRA position statements and responses.. To go to it,.. UKHRA application form back online.. If you support our aims and haven't filled one in please.. to get it (30/11/02).. FDAP site added to the.. (29/11/02).. SMMGP site added to the.. If you've got any relevant sites, please.. and send us an email telling us about them (27/11/02).. UKHRA website launched with a new look, and a new sponsor (22/11/02)..

    Original link path: /whatsnew.html
    Open archive

  • Title: UKHRA position statements & responses
    Descriptive info: UKHRA position statements responses.. UKHRA seeks to influence public policy and practice in many ways.. Where possible we respond to Government consultation on proposed policy and law changes, we also aim to publish guidance and proposals on policy and practice issues.. This page links to the responses, policy proposals and statements UKHRA has made:.. A.. consensus best practice statement.. has been published by the.. To read the online version,.. UKHRA Stakeholder Questionnaire Survey.. - download our findings.. to download survey in pdf format.. UKHRA Stakeholder Interviews.. -.. download our findings.. Consultation on Northern Ireland drug strategy.. 06: For diverse reasons, Northern Ireland's drug services are seriously out of step with many aspects of good practice now taken for granted elsewhere in the UK.. To download a Word version of the response,.. UK Diamorphine shortage.. 09.. 05: UKHRA calls for urgent action to end the shortage of injectable diamorphine that is causing serious hardship and risking the lives of drug users whose treatment has been stopped or changed.. To read the full statement,.. To download a Word version of the statement,.. US pressure to silence United Nations support for harm reduction and needle exchange - response update.. UKHRA is a signatory organisation to the open letter to the delegates of the Forty-eighth session of the Commission on Narcotic Drugs (CND), which was submitted on March 1st 2005.. See the dowloadable pdf file (.. available here.. ) for details of the full list of signatories.. Thanks to all who signed up.. Further updates will be be posted as things develop.. download pdf file.. 'Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study'.. UKHRA has issued a position statement on.. abstinence oriented drug education programmes.. To read the UKHRA response to the.. Strategic Framework and Action Plan for the Prevention and Control of Hepatitis C in Northern Ireland.. ,.. Protest at award for Thai prime minister.. Human Rights Watch and the Open Society Institute have jointly issued the letter below.. Thai Prime Minister Thaksin Shinawatra has been granted the annual 'International Forgiveness Award' by the Italian organization Instituzione Perdonanza Celestiniana for his 'treatment of drug abusers as patients, not criminals.. ' A group of more than  ...   order to clarify the situation UKHRA has prepared a definition of harm reduction, and identified the core principles of harm reduction.. In 2001 UKHRA along with other organisations.. issued a warning about the introduction of Difficult To Reuse Syringes.. (DTRS).. The position of UKRHA on this issue remains unchanged.. To read the statement,.. To read the UKHRA.. response to the.. Home Office PUBLIC CONSULTATION: COMPUTER GENERATED PRESCRIPTIONS, REGISTERS AND REQUISITIONS FOR CONTROLLED DRUGS.. From the archives:.. The speech that started it all off, and the original declaration of principle.. Now online, the full text of the speech given by Gerry Stimson at the Methadone Alliance Conference Methadone and Beyond: expanding and exploring drug treatment options on the 22nd March 2000 in London.. This speech led to a meeting of harm reduction activists at the international harm reduction conference in Jersey, and a meeting in Manchester where our first declaration of principle was drafted.. UKHRA is supporting an.. international day of action in support of Thai drug users on 12th June.. (please note, this is a new date).. For more information on the planned actions please.. There is also more information, and discussion about responses on the UKHRA.. discussion list, to join,.. UKHRA has responded to the Department of Health on the.. Office of Fair Trading report which recommended increased competition and freedom for supermarkets to be able to provide pharmacy services.. To read the latest update on this issue,.. formal response to the Home Office consultation on section 9a of the misuse of drugs act.. the 'paraphernalia law' that advocates the repeal of this unhelpful legislation.. Response of the UK Harm Reduction Alliance to the.. Hepatitis C Strategy for England.. , Autumn 2002.. Submission to The Home Affairs Select Committee on the Government's drug policy.. from The United Kingdom Harm Reduction Alliance (UKHRA), July 2001.. 'The 5th Amendment'.. the online version of the influential UKHRA proposal for the national drug strategies to include an additional fifth aim: Individual Health - to minimise the harm to the health of individuals and communities arising from drug use.. Published in 2001 in the hope of influencing the revised strategy which was, at that time, being drafted.. Also available as a pdf file (384KB).. To download,..

    Original link path: /statements.html
    Open archive

  • Title: UKHRA - Practice development
    Descriptive info: Practice Development.. This section of the site allows practitioners to share policies, protocols,and other useful documents with colleagues.. Documents are usually posted as a result of questions or debate on the ukhra email discussion groups.. These documents have been provided by workers and organisations in the interests improving service provision.. The information is provided on the basis that the source will be acknowledged by organisations who make use of it, and that improvments and alterations will be made available to others via this website.. If you have a document suitable for sharing on this site, or one that you have amended, please.. to send us an email to tell us about it.. Their inclusion on the site does not consititute an endorsement by UKHRA, nor do any of the contents necessarily reflect the views of the organisation.. Carl Chapple, Homelessness Policy Campaigns Officer at Cymorth Cymru,.. has posted an excellent.. sample drugs policy and accompanying guidance.. (publication of which was funded by the Welsh Assembley Government) for accommodation services specifically designed to work with drug or alcohol users.. The policy and guidance are aimed at servies such as wet houses or other projects with a drug related specialism, as well as services which provide more generic, non-specialist support or accommodation, such as homelessness hostels, refuges, night shelters, day centres and  ...   and offer practical solutions for those wanting to effectively engage service users in all aspects of service design, development and delivery.. To download the National Institute for Mental Health in England (NIMHE) guidance,.. To download their payments policy,.. It is hoped that this section will be expanded by local examples of good practice and research in this area.. TB is an increasing problem.. for injecting drug users.. To see a sample action plan and patient leaflet developed by Mari Ottridge/East Surrey needle exchange,.. Shooting up.. is an excellent report from the Health Protection Agency providing a good overview of the problem of viral transmission amongst injecting drug userse, and sensible recommendations for commissioning services to prevent the spread of blood borne viruses.. To download a pdf file of the report,.. To read the key points,.. Needle exchange in custody: procedure.. Needle exchange in custody: protocol.. Documents provided by Michael Appleton/KCA (contactable at:.. hepcreply@hotmail.. There are a number of assessment, screening, referral, triage, care plan and outcome measurement resources on the.. National Treatment Agency website.. The design of the NTA site means we can't link you to the page directly, but.. if you.. a new window will open with the NTA website, when you get.. there:.. go to 'publications'.. click on the 'models of care' link.. click on the 'toolkit' link..

    Original link path: /practice_development/practice_development.html
    Open archive



  •  


    Archived pages: 54